how to prevent pancreatitis while on semaglutide Reconciling GLP-1s and Acute Pancreatitis - Symptoms, Causes

It works best for individuals who are otherwise healthy but need a quick boost to get started on their weight loss journey

Generate a new calculator screenshot for your phone so you have a quick reference for the next four weeks

Body composition changes that improve health and appearance can occur even when scale weight temporarily stalls or moves in unexpected directions

Probiotics with well-researched strains like Lactobacillus rhamnosus GG or Bifidobacterium lactis BB-12

Key Takeaways Gastrointestinal events are the most common adverse effects: Nausea, diarrhea, and vomiting were reported in 4067% of participants at higher doses in published Phase 2 trial data Adverse events are dose-dependent: Higher retatrutide doses consistently produced higher rates of GI events across all published trials Most adverse events were mild to moderate: The Phase 2 trial reported the majority of events as Grade 1-2 in severity Discontinuation rates ranged from 610%: Published data shows dropout rates due to adverse events were comparable to other GLP-1 class compounds Retatrutide is not FDA-approved: All safety data comes from investigational clinical trials it remains a research compound What Clinical Trials Tell Us About Retatrutide Adverse Events Retatrutide (LY3437943) is an investigational triple-agonist peptide targeting GLP-1, GIP, and glucagon receptors simultaneously